miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Cell

Volumn 140, Issue 5, 2010, Pages 652-665

  Eiring, Anna M ^a   Harb, Jason G ^a   Neviani, Paolo ^a   Garton, Christopher ^a   Oaks, Joshua J ^a   Spizzo, Riccardo ^d   Liu, Shujun ^a   Schwind, Sebastian ^a,b   Santhanam, Ramasamy ^a   Hickey, Christopher J ^a,b   Becker, Heiko ^a,b   Chandler, Jason C ^a   Andino, Raul ^c   Cortes, Jorge ^d   Hokland, Peter ^e   Huettner, Claudia S ^f   Bhatia, Ravi ^g   Roy, Denis C ^h   Liebhaber, Stephen A ⁱ   Caligiuri, Michael A ^a,b   Marcucci, Guido ^a,b   Garzon, Ramiro ^a,b   Croce, Carlo M ^a,b   Calin, George A ^d   Perrotti, Danilo ^a,b   more..

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Center for RNA Interference and Non Coding RNA   (United States)

^e AARHUS UNIVERSITY   (Denmark)

^f HARVARD MEDICAL SCHOOL   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

HUMDISEASE; RNA

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN E2; MESSENGER RNA; MICRORNA; MICRORNA 328; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE PIM 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASE PAIRING; BLAST CELL CRISIS; CELL FATE; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA SEQUENCE; RNA TRANSLATION; TRANSLATION REGULATION;

EID: 77649133970     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.01.007     Document Type: Article

References (45)

1. Agirre X., Jimenez-Velasco A., San Jose-Eneriz E., Garate L., Bandres E., Cordeu L., Aparicio O., Saez B., Navarro G., Vilas-Zornoza A., et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol. Cancer Res. 6 (2008) 1830-1840
2. Bartel D.P. MicroRNAs: Target recognition and regulatory functions. Cell 136 (2009) 215-233
3. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107 (2001) 477-487
4. Bueno M.J., Perez de Castro I., Gomez de Cedron M., Santos J., Calin G.A., Cigudosa J.C., Croce C.M., Fernandez-Piqueras J., and Malumbres M. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13 (2008) 496-506
5. Carpenter B., MacKay C., Alnabulsi A., MacKay M., Telfer C., Melvin W.T., and Murray G.I. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim. Biophys. Acta 1765 (2006) 85-100
6. Chang J.S., Santhanam R., Trotta R., Neviani P., Eiring A.M., Briercheck E., Ronchetti M., Roy D.C., Calabretta B., Caligiuri M.A., and Perrotti D. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood 110 (2007) 994-1003
7. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
8. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., and Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436 (2005) 740-744
9. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., and Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107 (2001) 489-499
10. Eiring A.M., Neviani P., Santhanam R., Oaks J.J., Chang J.S., Notari M., Willis W., Gambacorti-Passerini C., Volinia S., Marcucci G., et al. Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis. Blood 111 (2008) 816-828
11. Evans J.R., Mitchell S.A., Spriggs K.A., Ostrowski J., Bomsztyk K., Ostarek D., and Willis A.E. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22 (2003) 8012-8020
12. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., and Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123 (2005) 819-831
13. Ferrari-Amorotti G., Keeshan K., Zattoni M., Guerzoni C., Iotti G., Cattelani S., Donato N.J., and Calabretta B. Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha. Blood 108 (2006) 1353-1362
14. Friedman R.C., Farh K.K., Burge C.B., and Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (2009) 92-105
15. Fujimura K., Kano F., and Murata M. Identification of PCBP2, a facilitator of IRES-mediated translation, as a novel constituent of stress granules and processing bodies. RNA 14 (2008) 425-431
16. Garzon R., Fabbri M., Cimmino A., Calin G.A., and Croce C.M. MicroRNA expression and function in cancer. Trends Mol. Med. 12 (2006) 580-587
17. George A.D., and Tenenbaum S.A. MicroRNA modulation of RNA-binding protein regulatory elements. RNA Biol. 3 (2006) 57-59
18. Glisovic T., Bachorik J.L., Yong J., and Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 582 (2008) 1977-1986
19. Guil S., and Caceres J.F. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat. Struct. Mol. Biol. 14 (2007) 591-596
20. Hinman M.N., and Lou H. Diverse molecular functions of Hu proteins. Cell. Mol. Life Sci. 65 (2008) 3168-3181
21. Hoover R.R., Gerlach M.J., Koh E.Y., and Daley G.Q. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells. Oncogene 20 (2001) 5826-5835
22. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., Gotlib J., Li K., Manz M.G., Keating A., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351 (2004) 657-667
23. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., and Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451 (2008) 1125-1129
24. Keene J.D. RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 8 (2007) 533-543
25. Keene J.D., Komisarow J.M., and Friedersdorf M.B. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat. Protoc. 1 (2006) 302-307
26. Keeshan K., Santilli G., Corradini F., Perrotti D., and Calabretta B. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Blood 102 (2003) 1267-1275
27. Khabar K.S. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res. 25 (2005) 1-10
28. Lal A., Mazan-Mamczarz K., Kawai T., Yang X., Martindale J.L., and Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 23 (2004) 3092-3102
29. Makeyev A.V., and Liebhaber S.A. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8 (2002) 265-278
30. Melo J.V., and Barnes D.J. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat. Rev. Cancer 7 (2007) 441-453
31. Nieborowska-Skorska M., Hoser G., Kossev P., Wasik M.A., and Skorski T. Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood 99 (2002) 4531-4539
32. Notari M., Neviani P., Santhanam R., Blaser B.W., Chang J.S., Galietta A., Willis A.E., Roy D.C., Caligiuri M.A., Marcucci G., and Perrotti D. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107 (2006) 2507-2516
33. Ostareck-Lederer A., and Ostareck D.H. Control of mRNA translation and stability in haematopoietic cells: the function of hnRNPs K and E1/E2. Biol. Cell 96 (2004) 407-411
34. Parker R., and Sheth U. P bodies and the control of mRNA translation and degradation. Mol. Cell 25 (2007) 635-646
35. Perrotti D., Cesi V., Trotta R., Guerzoni C., Santilli G., Campbell K., Iervolino A., Condorelli F., Gambacorti-Passerini C., Caligiuri M.A., and Calabretta B. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat. Genet. 30 (2002) 48-58
36. Perrotti D., and Neviani P. From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way. Clin. Cancer Res. 13 (2007) 1638-1642
37. Rosmarin A.G., Weil S.C., Rosner G.L., Griffin J.D., Arnaout M.A., and Tenen D.G. Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood 73 (1989) 131-136
38. Schultheis B., Szydlo R., Mahon F.X., Apperley J.F., and Melo J.V. Analysis of total phosphotyrosine levels in CD34+ cells from CML patients to predict the response to imatinib mesylate treatment. Blood 105 (2005) 4893-4894
39. Tenen D.G. Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer 3 (2003) 89-101
40. Vasudevan S., Tong Y., and Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318 (2007) 1931-1934
41. Venturini L., Battmer K., Castoldi M., Schultheis B., Hochhaus A., Muckenthaler M.U., Ganser A., Eder M., and Scherr M. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109 (2007) 4399-4405
42. Wagner K., Zhang P., Rosenbauer F., Drescher B., Kobayashi S., Radomska H.S., Kutok J.L., Gilliland D.G., Krauter J., and Tenen D.G. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy. Proc. Natl. Acad. Sci. USA 103 (2006) 6338-6343
43. Wang C.H., Lee D.Y., Deng Z., Jeyapalan Z., Lee S.C., Kahai S., Lu W.Y., Zhang Y., and Yang B.B. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS ONE 3 (2008) e2420
44. Wang W., Wang X., Ward A.C., Touw I.P., and Friedman A.D. C/EBPalpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes. Leukemia 15 (2001) 779-786
45. Zalfa F., Giorgi M., Primerano B., Moro A., Di Penta A., Reis S., Oostra B., and Bagni C. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112 (2003) 317-327